Kymera Therapeutics Inc
NASDAQ:KYMR
Kymera Therapeutics Inc
NASDAQ:KYMR
Price:
88.53
USD
4.09%
Market Closed
Market Cap:
$7.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kymera Therapeutics Inc
NASDAQ:KYMR
|
US |
Income Statement
Earnings Waterfall
Kymera Therapeutics Inc
Kymera Therapeutics Inc
Income Statement
Kymera Therapeutics Inc
Kymera Therapeutics Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
34
N/A
|
46
+35%
|
65
+40%
|
70
+9%
|
73
+4%
|
64
-12%
|
57
-11%
|
46
-19%
|
47
+2%
|
47
0%
|
52
+11%
|
47
-9%
|
79
+68%
|
79
+1%
|
89
+12%
|
88
-1%
|
47
-46%
|
59
+25%
|
45
-24%
|
44
-2%
|
39
-10%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(80)
|
(80)
|
(123)
|
(150)
|
(173)
|
(188)
|
(197)
|
(203)
|
(208)
|
(216)
|
(224)
|
(232)
|
(244)
|
(253)
|
(269)
|
(283)
|
(304)
|
(337)
|
(357)
|
(372)
|
(385)
|
|
| Selling, General & Administrative |
(18)
|
(18)
|
(26)
|
(30)
|
(36)
|
(41)
|
(44)
|
(44)
|
(44)
|
(46)
|
(49)
|
(52)
|
(55)
|
(57)
|
(60)
|
(61)
|
(64)
|
(65)
|
(66)
|
(68)
|
(68)
|
|
| Research & Development |
(62)
|
(62)
|
(97)
|
(120)
|
(137)
|
(147)
|
(153)
|
(159)
|
(164)
|
(171)
|
(175)
|
(179)
|
(189)
|
(196)
|
(209)
|
(221)
|
(240)
|
(272)
|
(291)
|
(305)
|
(317)
|
|
| Operating Income |
(46)
N/A
|
(34)
+27%
|
(59)
-73%
|
(79)
-35%
|
(101)
-27%
|
(124)
-24%
|
(140)
-13%
|
(157)
-12%
|
(161)
-3%
|
(170)
-5%
|
(172)
-2%
|
(185)
-7%
|
(166)
+10%
|
(173)
-5%
|
(181)
-4%
|
(195)
-8%
|
(257)
-31%
|
(278)
-8%
|
(312)
-12%
|
(328)
-5%
|
(346)
-5%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
1
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
6
|
11
|
15
|
17
|
19
|
23
|
28
|
33
|
38
|
37
|
36
|
37
|
38
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
(5)
|
(5)
|
0
|
0
|
(4)
|
(4)
|
|
| Pre-Tax Income |
(46)
N/A
|
(34)
+26%
|
(58)
-73%
|
(79)
-35%
|
(100)
-27%
|
(124)
-24%
|
(139)
-13%
|
(154)
-10%
|
(155)
-1%
|
(159)
-3%
|
(158)
+1%
|
(167)
-6%
|
(147)
+12%
|
(155)
-5%
|
(158)
-2%
|
(167)
-6%
|
(224)
-34%
|
(241)
-8%
|
(275)
-14%
|
(295)
-7%
|
(311)
-5%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(46)
|
(34)
|
(58)
|
(79)
|
(100)
|
(124)
|
(139)
|
(154)
|
(155)
|
(159)
|
(158)
|
(167)
|
(147)
|
(155)
|
(158)
|
(167)
|
(224)
|
(241)
|
(275)
|
(295)
|
(311)
|
|
| Net Income (Common) |
(55)
N/A
|
(34)
+38%
|
(58)
-73%
|
(79)
-35%
|
(100)
-27%
|
(124)
-24%
|
(139)
-13%
|
(154)
-10%
|
(155)
-1%
|
(159)
-3%
|
(158)
+1%
|
(167)
-6%
|
(147)
+12%
|
(155)
-5%
|
(158)
-2%
|
(167)
-6%
|
(224)
-34%
|
(241)
-8%
|
(275)
-14%
|
(295)
-7%
|
(311)
-5%
|
|
| EPS (Diluted) |
-1.23
N/A
|
-0.76
+38%
|
-1.31
-72%
|
-1.55
-18%
|
-2.09
-35%
|
-2.39
-14%
|
-2.71
-13%
|
-2.82
-4%
|
-2.87
-2%
|
-2.73
+5%
|
-2.7
+1%
|
-2.87
-6%
|
-2.52
+12%
|
-2.18
+13%
|
-2.16
+1%
|
-2.19
-1%
|
-2.98
-36%
|
-3
-1%
|
-3.42
-14%
|
-3.38
+1%
|
-3.69
-9%
|
|
Switch to:
Switch to:
See Also
Discover More
